This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Funds

1

Reported GAV

$575Mgross asset value on Form ADV; never dry powder

Funds with fundraising evidence

0derived

Investments

3

Portfolio companies

3

Investments, 12m

3

Partner-attributed

0

People

18

Investment professionals

15derived

Co-investors

0derived

LP relationships

0

Stated sectors

healthcare,biotech,medtech,energy,hardware,robotics,logistics,industrialas stated by the firm

Stated geography

asia,global,japan,north america,seattle,singapore,usa,worldwide

Latest Form D

Sep 26, 2019

Latest ADV filing

Mar 29, 2024

Website

lyfecapital.com

• Occurred

  Mar 22, 2022
  Person left

  Zhengkun Yu (Shareholder) no longer on Schedule A of Lyfe Capital Management Limited

  Form ADVobserved 6 days ago
• Occurred

  Nov 26, 2019
  Adviser's first ADV filing

  Lyfe Capital Management Limited first filed Form ADV (ERA, venture capital fund adviser exemption)

  Form ADVobserved 6 days ago

Also named here, with no published line of their own (reach them through the firm): Frances Chovanec (Managing Director), Jack Chen (Partner), William Chen (Partner), Yao Li Ho (Managing Director), Alvin Koh (Investment Principal and Senior Director, APAC Business Development), Fong Ming Koh (Principal), Peter Lee (Managing Director), David Liu (Director of Investor Relations), Vivien Li (Director of Business Development), Derek Yuan (Partner), James Zhao (Founder and Partner), Laura Lu (Chief Legal Officer).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:3bc6a3c9-3119-43c0-ac8e-5cdfedef7778

First observed

Sep 12, 2026

Last observed

Sep 17, 2026 46 h ago

Source families

Federal regulator filings, Firm and issuer disclosures

2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.